United States · FDA National Drug Code directory
Diflunisal
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70771-1083_d5395b92-79af-436c-82ac-a6b70cd3b139
- Product NDC
- 70771-1083
- Form
- TABLET
- Composition / generic term
- Diflunisal
- Labeler
- Zydus Lifesciences Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170914
- Source listing expiry
- 20261231
Source-listed ingredients
- DIFLUNISAL — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET in 1 BOTTLE (70771-1083-0) · 70771-1083-0
- 100 TABLET in 1 BOTTLE (70771-1083-1) · 70771-1083-1
- 30 TABLET in 1 BOTTLE (70771-1083-3) · 70771-1083-3
- 500 TABLET in 1 BOTTLE (70771-1083-5) · 70771-1083-5
- 60 TABLET in 1 BOTTLE (70771-1083-6) · 70771-1083-6
- 10 BLISTER PACK in 1 CARTON (70771-1083-8) / 10 TABLET in 1 BLISTER PACK · 70771-1083-8
- 90 TABLET in 1 BOTTLE (70771-1083-9) · 70771-1083-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →